Kadsurenone is a useful and promising treatment strategy for breast cancer bone metastases by blocking the PAF/PTAFR signaling pathway

Breast cancer (BC) is characterized by high incidences of bone metastases. Current treatment strategies for BC bone metastases primarily focused on breaking the ‘vicious osteolytic cycle’. Platelet-activating factor (PAF) is a potent phospholipid mediator, which has previously reported biological ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Tianhui, Lou, Yan, Li, Shichang, Zhao, Chenglong, Ji, Yingzheng, Wang, Dongsheng, Tang, Liang, Zhou, Ming, Xu, Wei, Qian, Ming, Wu, Zhipeng, Zhao, Jian, Wei, Haifeng, Li, Zhenxi, Xiao, Jianru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036417/
https://www.ncbi.nlm.nih.gov/pubmed/30008927
http://dx.doi.org/10.3892/ol.2018.8935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036417/
https://www.ncbi.nlm.nih.gov/pubmed/30008927
http://dx.doi.org/10.3892/ol.2018.8935

Ejemplares similares